Hiroaki Akasaka, Fumiya K Sano, Wataru Shihoya, Osamu Nureki
{"title":"非脂质碱性激动剂强效激活溶血磷脂酸受体 1 的结构机制。","authors":"Hiroaki Akasaka, Fumiya K Sano, Wataru Shihoya, Osamu Nureki","doi":"10.1038/s42003-024-07152-y","DOIUrl":null,"url":null,"abstract":"<p><p>Lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) is one of the G protein-coupled receptors activated by the lipid mediator, lysophosphatidic acid (LPA). LPA<sub>1</sub> is associated with a variety of diseases, and LPA<sub>1</sub> agonists have potential therapeutic value for treating obesity and depression. Although potent nonlipid LPA<sub>1</sub> agonists have recently been identified, the mechanisms of nonlipid molecule-mediated LPA<sub>1</sub> activation remain unclear. Here, we report a cryo-electron microscopy structure of the human LPA<sub>1</sub>-G<sub>i</sub> complex bound to a nonlipid basic agonist, CpY, which has 30-fold higher agonistic activity as compared with LPA. Structural comparisons of LPA<sub>1</sub> with other lipid GPCRs revealed that the negative charge in the characteristic binding pocket of LPA<sub>1</sub> allows the selective recognition of CpY, which lacks a polar head. In addition, our structure show that the ethyl group of CpY directly pushes W271<sup>6.48</sup> to fix the active conformation. Endogenous LPA lacks these chemical features, which thus represent the crucial elements of nonlipid agonists that potently activate LPA<sub>1</sub>. This study provides detailed mechanistic insights into the ligand recognition and activation of LPA<sub>1</sub> by nonlipid agonists, expanding the scope for drug development targeting the LPA receptors.</p>","PeriodicalId":10552,"journal":{"name":"Communications Biology","volume":null,"pages":null},"PeriodicalIF":5.2000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541586/pdf/","citationCount":"0","resultStr":"{\"title\":\"Structural mechanisms of potent lysophosphatidic acid receptor 1 activation by nonlipid basic agonists.\",\"authors\":\"Hiroaki Akasaka, Fumiya K Sano, Wataru Shihoya, Osamu Nureki\",\"doi\":\"10.1038/s42003-024-07152-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) is one of the G protein-coupled receptors activated by the lipid mediator, lysophosphatidic acid (LPA). LPA<sub>1</sub> is associated with a variety of diseases, and LPA<sub>1</sub> agonists have potential therapeutic value for treating obesity and depression. Although potent nonlipid LPA<sub>1</sub> agonists have recently been identified, the mechanisms of nonlipid molecule-mediated LPA<sub>1</sub> activation remain unclear. Here, we report a cryo-electron microscopy structure of the human LPA<sub>1</sub>-G<sub>i</sub> complex bound to a nonlipid basic agonist, CpY, which has 30-fold higher agonistic activity as compared with LPA. Structural comparisons of LPA<sub>1</sub> with other lipid GPCRs revealed that the negative charge in the characteristic binding pocket of LPA<sub>1</sub> allows the selective recognition of CpY, which lacks a polar head. In addition, our structure show that the ethyl group of CpY directly pushes W271<sup>6.48</sup> to fix the active conformation. Endogenous LPA lacks these chemical features, which thus represent the crucial elements of nonlipid agonists that potently activate LPA<sub>1</sub>. This study provides detailed mechanistic insights into the ligand recognition and activation of LPA<sub>1</sub> by nonlipid agonists, expanding the scope for drug development targeting the LPA receptors.</p>\",\"PeriodicalId\":10552,\"journal\":{\"name\":\"Communications Biology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2024-11-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541586/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Communications Biology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1038/s42003-024-07152-y\",\"RegionNum\":1,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communications Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s42003-024-07152-y","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOLOGY","Score":null,"Total":0}
Structural mechanisms of potent lysophosphatidic acid receptor 1 activation by nonlipid basic agonists.
Lysophosphatidic acid receptor 1 (LPA1) is one of the G protein-coupled receptors activated by the lipid mediator, lysophosphatidic acid (LPA). LPA1 is associated with a variety of diseases, and LPA1 agonists have potential therapeutic value for treating obesity and depression. Although potent nonlipid LPA1 agonists have recently been identified, the mechanisms of nonlipid molecule-mediated LPA1 activation remain unclear. Here, we report a cryo-electron microscopy structure of the human LPA1-Gi complex bound to a nonlipid basic agonist, CpY, which has 30-fold higher agonistic activity as compared with LPA. Structural comparisons of LPA1 with other lipid GPCRs revealed that the negative charge in the characteristic binding pocket of LPA1 allows the selective recognition of CpY, which lacks a polar head. In addition, our structure show that the ethyl group of CpY directly pushes W2716.48 to fix the active conformation. Endogenous LPA lacks these chemical features, which thus represent the crucial elements of nonlipid agonists that potently activate LPA1. This study provides detailed mechanistic insights into the ligand recognition and activation of LPA1 by nonlipid agonists, expanding the scope for drug development targeting the LPA receptors.
期刊介绍:
Communications Biology is an open access journal from Nature Research publishing high-quality research, reviews and commentary in all areas of the biological sciences. Research papers published by the journal represent significant advances bringing new biological insight to a specialized area of research.